Cargando...
Antibodies to watch in 2018
The pace of antibody therapeutics development accelerated in 2017, and this faster pace is projected to continue through 2018. Notably, the annual number of antibody therapeutics granted a first approval in either the European Union (EU) or United States (US) reached double-digits (total of 10) for...
Guardado en:
| Publicado en: | MAbs |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5825203/ https://ncbi.nlm.nih.gov/pubmed/29300693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1415671 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|